Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

NCT01614990 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDIV

Sponsor class

Conditions

Cancer Cachexia

Interventions

DRUG: Macimorelin
DRUG: Placebo

Sponsor

Garcia, Jose M., MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]